Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
58 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
CoBioRes from Leuven, company number BE0525845116, closed financial year 2025 with a result of € -28,827 after tax. For that financial year CoBioRes recorded a gross margin of € -28,361 and equity of € 337,767. Compared with financial year 2024, the result moved from € -9,658 to € -28,827. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 337,767
▼ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -28,827
▼ 198 % more loss than in 2024
Profit after tax over the fiscal year.
€ 248,783
▲ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -7.7 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 247
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -56,959 | € -48,357 | € -10,249 | € -28,361 | ▼ € 18,112 |
| Profit after taxes | € -63,215 | € -52,916 | € -9,658 | € -28,827 | ▼ € 19,169 |
| Equity | € 429,167 | € 376,251 | € 366,593 | € 337,767 | ▼ 8% |
| Total debts | € 0 | € 4,376 | € 0 | € 247 | |
| Cash | € 92,860 | € 112,803 | € 165,215 | € 248,783 | ▲ 51% |
| Retained profit | € -7,570,833 | € -7,623,749 | € -7,633,407 | € -7,662,233 | |
| Balance sheet total | € 429,167 | € 380,627 | € 366,593 | € 338,014 | ▼ 8% |
Key figures of CoBioRes, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CoBioRes?
What happened at CoBioRes in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Desire COLLEN stepped down as director. NBB
- SOFIA BVBA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 28,827. Source: NBB ↗
- Desire COLLEN became a director. NBB
- SOFIA BVBA became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,215 loss in 2022 to € 28,827 loss in 2025.
Paid € 1,019 in corporate taxes since 2022.
A new publication or filing at CoBioRes? We notify you, reason included.
Follow CoBioResDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Life Sciences Research Partners comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CoBioResThe shares are held by Life Sciences Research Partners (100%).
Directors
According to the 2025 annual accounts
since 2022 · until 2028
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Herestraat 49 box 913
3000 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 58 companies are registered at this address.
All companies at this address →The Association for European Paediatric and Congenital Cardiology
Stfran.
€ 75,987 revenue · 2023
ALFAGEN: Alumni van de FAculteit GENeeskunde KU Leuven
Rega Instituut
€ -7,459 gross margin · 2025
Vlaamse Vereniging voor Seksuologie
+53 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0525.845.116
- VAT number
- BE 0525.845.116
- Registered office
- Herestraat 49 bus 913, 3000 Leuven
- Names & denominations
- CoBioRes
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 March 2013
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied